| Year |
Citation |
Score |
| 2024 |
Kamusiime B, Beima-Sofie K, Chhun N, Nalumansi A, Nalukwago GK, Kasiita V, Twesige CC, Kansiime R, Muwonge TR, Kyambadde P, Kadama H, Mudiope P, Glick S, Lambdin B, Mujugira A, ... Heffron R, et al. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda. Addiction Science & Clinical Practice. 19: 13. PMID 38395940 DOI: 10.1186/s13722-024-00444-y |
0.331 |
|
| 2024 |
Wang L, Muwonge TR, Simoni JM, Nambi F, Nakabugo L, Kibuuka J, Thomas D, Katz IT, Feutz E, Thomas KK, Ware NC, Wyatt MA, Kadama H, Mujugira A, Heffron R. Behavioral Modeling and its Association with PrEP and ART Use in Ugandan HIV-Serodifferent Couples. Aids and Behavior. PMID 38361169 DOI: 10.1007/s10461-024-04286-2 |
0.504 |
|
| 2024 |
Zia Y, Etyang L, Nyerere B, Nyamwaro C, Mogaka F, Mwangi M, June L, Njiru R, Mokoyo J, Kimani S, Thomas KK, Ngure K, Wanyama I, Bukusi E, Mugo N, ... Heffron R, et al. Structural influences on delivery and use of oral HIV PrEP among adolescent girls and young women seeking post abortion care in Kenya. Eclinicalmedicine. 68: 102416. PMID 38292038 DOI: 10.1016/j.eclinm.2023.102416 |
0.593 |
|
| 2023 |
Thomas D, Nakabugo L, Nambi F, Kibuuka J, Muwonge T, Feutz E, Thomas K, Simoni J, Montgomery E, Ware N, Wyatt M, Katz IT, Kadama H, Mujugira A, Heffron R. Intimate partner violence and adherence to PrEP and ART among Ugandan HIV serodifferent couples. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 38133584 DOI: 10.1097/QAI.0000000000003368 |
0.644 |
|
| 2023 |
Thomas D, Nalumansi A, Reichman M, Metitiri M, Kamusiime B, Kasiita V, Nalukwago GK, Kibuuka J, Nakabugo L, Nambi F, Muwonge T, Simoni J, Montgomery ET, Ware N, Wyatt MA, ... ... Heffron R, et al. "Gender-based Violence (GBV) and HIV, they are like sister and brother": barriers and facilitators to GBV screening and referral in public HIV treatment settings in Uganda. Bmc Health Services Research. 23: 1383. PMID 38082407 DOI: 10.1186/s12913-023-10400-2 |
0.585 |
|
| 2023 |
Reddy K, Palanee-Phillips T, Heffron R. Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa. Current Hiv/Aids Reports. 20: 333-344. PMID 38051383 DOI: 10.1007/s11904-023-00680-y |
0.521 |
|
| 2023 |
Mugo NR, Mudhune V, Heffron R, Thomas KK, McLellan-Lemal E, Njoroge B, Peacock S, O'Connor SM, Nyagol B, Ouma E, Ridzon R, Wiener J, Isoherranen N, Erikson DW, Ouattara LA, et al. Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya. Frontiers in Reproductive Health. 5: 1118030. PMID 37383290 DOI: 10.3389/frph.2023.1118030 |
0.606 |
|
| 2023 |
Beesham I, Milford C, Smit J, Joseph Davey DL, Baeten JM, Heffron R, Beksinska M, Mansoor LE. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa. Bmc Public Health. 23: 1210. PMID 37349816 DOI: 10.1186/s12889-023-16139-z |
0.522 |
|
| 2023 |
Dabee S, Balle C, Onono M, Innes S, Nair G, Palanee-Phillips T, Burgener AD, Bosinger SE, Passmore JS, Heffron R, Jaspan H, Happel AU. Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections. Current Hiv/Aids Reports. PMID 37341916 DOI: 10.1007/s11904-023-00662-0 |
0.575 |
|
| 2023 |
Rousseau E, Wu L, Heffron R, Baeten JM, Celum CL, Travill D, Delany-Moretlwe S, Bekker LG, Bukusi E, Omollo V, van der Straten A, O'Malley G, Haberer JE, Morton JF, Johnson RE, et al. Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa. Frontiers in Reproductive Health. 5: 1073103. PMID 37325240 DOI: 10.3389/frph.2023.1073103 |
0.492 |
|
| 2023 |
Nakalega R, Mukiza N, Menge R, Kizito S, Babirye JA, Kuteesa CN, Mawanda D, Mulumba E, Nabukeera J, Ggita J, Nakanjako L, Akello C, Mirembe BG, Lukyamuzi Z, Nakaye C, ... ... Heffron R, et al. Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda. Bmc Public Health. 23: 1163. PMID 37322510 DOI: 10.1186/s12889-023-16081-0 |
0.617 |
|
| 2023 |
Ware NC, Wyatt MA, Pisarski EE, Nalumansi A, Kasiita V, Kamusiime B, Nalukwago GK, Thomas D, Kibuuka J, Muwonge T, Mujugira A, Heffron R. How Central Ugandan HIV Clinics Adapted During COVID-19 Lockdown Restrictions to Promote Continuous Access to Care: A Qualitative Analysis. Aids and Behavior. PMID 37266823 DOI: 10.1007/s10461-023-04090-4 |
0.554 |
|
| 2023 |
Zia Y, Nambala L, Stalter RM, Muwonge TR, Ssebuliba T, Nakyanzi A, Nampewo O, Boyer J, Morrison S, Nsubuga R, Bagaya M, Nyanzi R, Matovu F, Yin M, Wyatt C, ... ... Heffron R, et al. Depression and PrEP uptake, interruption, and adherence among young women in Uganda. Aids Care. 1-10. PMID 36892945 DOI: 10.1080/09540121.2023.2177250 |
0.364 |
|
| 2023 |
Brown BP, Feng C, Tanko RF, Jaumdally SZ, Bunjun R, Dabee S, Happel AU, Gasper M, Nyangahu DD, Onono M, Nair G, Palanee-Phillips T, Scoville CW, Heller K, Baeten JM, ... ... Heffron R, et al. Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial. Nature Communications. 14: 499. PMID 36717556 DOI: 10.1038/s41467-023-36002-4 |
0.455 |
|
| 2022 |
Deese J, Chen PL, Gao X, Heffron R, Hobbs M, Lapple D, Jaspan H, Miller A, Nair G, Onono M, Palanee-Phillips T, Reddy K, Steiner MJ. Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial. Aids and Behavior. PMID 36357806 DOI: 10.1007/s10461-022-03834-y |
0.361 |
|
| 2022 |
Heffron R, Muwonge TR, Boyer J, Matovu F, Zia Y, Bagaya M, Ssebuliba T, Morrison S, Bambia F, Nsubuga R, Badaru J, Stein G, Mugwanya KK, Wyatt C, Baeten JM, et al. Bone mineral density, nutrient intake, and physical activity among young women from Uganda. Archives of Osteoporosis. 17: 134. PMID 36216962 DOI: 10.1007/s11657-022-01155-0 |
0.416 |
|
| 2022 |
McLellan-Lemal E, Deaton SR, Betts JE, Ondenge K, Mudhune V, O'Connor SM, Nyagol B, Thurman AR, Doncel GF, Allen SA, Heffron R, Mugo NR. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu combined ring study, 2019. Contemporary Clinical Trials. 122: 106935. PMID 36162740 DOI: 10.1016/j.cct.2022.106935 |
0.348 |
|
| 2022 |
Beesham I, Parikh UM, Mellors JW, Joseph Davey DL, Heffron R, Palanee-Phillips T, Bosman SL, Beksinska M, Smit J, Ahmed K, Makkan H, Selepe P, Louw C, Kotze P, Hofmeyr GJ, et al. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. Journal of Acquired Immune Deficiency Syndromes (1999). 91: 130-137. PMID 36094478 DOI: 10.1097/QAI.0000000000003027 |
0.729 |
|
| 2022 |
Heffron R, Muwonge TR, Thomas KK, Nambi F, Nakabugo L, Kibuuka J, Thomas D, Feutz E, Meisner A, Ware NC, Wyatt MA, Simoni JM, Katz IT, Kadama H, Baeten JM, et al. PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial. Eclinicalmedicine. 52: 101611. PMID 35990584 DOI: 10.1016/j.eclinm.2022.101611 |
0.743 |
|
| 2022 |
Mugambi ML, Pintye J, Heffron R, Barnabas RV, John-Stewart G. HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently? Current Hiv/Aids Reports. PMID 35984551 DOI: 10.1007/s11904-022-00621-1 |
0.604 |
|
| 2022 |
Beesham I, Mansoor LE, Joseph Davey DL, Palanee-Phillips T, Smit J, Ahmed K, Selepe P, Louw C, Singata-Madliki M, Kotze P, Heffron R, Parikh UM, Wiesner L, Rees H, Baeten JM, et al. Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial. Journal of Acquired Immune Deficiency Syndromes (1999). 91: 26-30. PMID 35972853 DOI: 10.1097/QAI.0000000000003023 |
0.692 |
|
| 2022 |
Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, ... ... Heffron R, et al. Initiating Intramuscular Depot Medroxyprogesterone Acetate (DMPA-IM) Increases Frequencies of Th17-like Human Immunodeficiency Virus (HIV) Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35941737 DOI: 10.1093/cid/ciac284 |
0.665 |
|
| 2022 |
Pyra M, Heffron R, Haberer JE, Kiarie J. HIV prevention metrics: lessons to be learned from contraception. Journal of the International Aids Society. 25: e25958. PMID 35929343 DOI: 10.1002/jia2.25958 |
0.607 |
|
| 2022 |
Njuguna N, Mugo N, Anzala O, Mureithi M, Irungu E, Wamicwe J, Baeten JM, Heffron R. An empiric tool to identify Kenyans living with HIV who will have unsuppressed viremia 18 months following treatment initiation to guide differentiated care models. Plos One. 17: e0271520. PMID 35853007 DOI: 10.1371/journal.pone.0271520 |
0.529 |
|
| 2022 |
Dabee S, Mugo N, Mudhune V, McLellan-Lemal E, Peacock S, O'Connor S, Njoroge B, Nyagol B, Thurman AR, Ouma E, Ridzon R, Wiener J, Haugen HS, Gasper M, Feng C, ... ... Heffron R, et al. Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya. Scientific Reports. 12: 12040. PMID 35835755 DOI: 10.1038/s41598-022-13475-9 |
0.433 |
|
| 2022 |
Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, ... ... Heffron R, et al. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project. Journal of the International Aids Society. 25: e25962. PMID 35822945 DOI: 10.1002/jia2.25962 |
0.702 |
|
| 2022 |
Mwongeli N, Wagner AD, Dettinger JC, Pintye J, Brown Trinidad S, Awuor M, Kimemia G, Ngure K, Heffron RA, Baeten JM, Mugo N, Bukusi EA, Kinuthia J, Kelley MC, John-Stewart GC, et al. " Healthcare Worker Perspectives on Using pre-Exposure Prophylaxis (PrEP) During Pregnancy and Postpartum in Kenya. Journal of the International Association of Providers of Aids Care. 21: 23259582221111068. PMID 35776525 DOI: 10.1177/23259582221111068 |
0.751 |
|
| 2022 |
Velloza J, Mujugira A, Muwonge T, Boyer J, Nampewo O, Badaru J, Ssebuliba T, Stalter RM, Stein G, Baeten JM, Celum C, Heffron R. A novel "HIV salience and Perception" scale is associated with PrEP dispensing and adherence among adolescent girls and young women in Kampala, Uganda. Aids and Behavior. PMID 35776250 DOI: 10.1007/s10461-022-03762-x |
0.655 |
|
| 2022 |
Palanee-Phillips T, Rees HV, Heller KB, Ahmed K, Batting J, Beesham I, Heffron R, Justman J, Makkan H, Mastro TD, Morrison SA, Mugo N, Nair G, Kiarie J, Philip NM, et al. High HIV incidence among young women in South Africa: Data from a large prospective study. Plos One. 17: e0269317. PMID 35657948 DOI: 10.1371/journal.pone.0269317 |
0.761 |
|
| 2022 |
Muwonge TR, Nsubuga R, Ware NC, Wyatt MA, Pisarski E, Kamusiime B, Kasiita V, Nalukwago GK, Brown C, Nakyanzi A, Bagaya M, Bambia F, Ssebuliba T, Katabira E, Kyambadde P, ... ... Heffron R, et al. Health Care Worker Perspectives of HIV Pre-exposure Prophylaxis Service Delivery in Central Uganda. Frontiers in Public Health. 10: 658826. PMID 35444979 DOI: 10.3389/fpubh.2022.658826 |
0.538 |
|
| 2022 |
Tanko RF, Bunjun R, Dabee S, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Harryparsad R, Happel AU, Gamieldien H, Qumbelo Y, Sinkala M, Scoville CW, Heller K, Baeten JM, ... ... Heffron R, et al. The Effect Of Contraception On Genital Cytokines In Women Randomized To Copper Intrauterine Device, Intramuscular Depot Medroxyprogesterone Acetate Or Levonorgestrel Implant. The Journal of Infectious Diseases. PMID 35263421 DOI: 10.1093/infdis/jiac084 |
0.582 |
|
| 2022 |
Ortblad KF, Mawandia S, Bakae O, Tau L, Grande M, Mogomotsi GP, Mmatli E, Ngombo M, Seckel L, Heffron R, Pintye J, Ledikwe J. Using routine programmatic data to measure HIV incidence among pregnant women in Botswana. Population Health Metrics. 20: 10. PMID 35246143 DOI: 10.1186/s12963-022-00287-2 |
0.653 |
|
| 2022 |
Thomas D, Mujugira A, Ortblad K, Namanda S, Kibuuka J, Nakitende M, Nambi F, Nakabugo L, Scoville C, Muwonge T, Heffron R. A pragmatic approach to identifying implementation barriers and facilitators for a novel pre-exposure prophylaxis (PrEP) delivery model at public facilities in urban Uganda. Implementation Science Communications. 3: 7. PMID 35090560 DOI: 10.1186/s43058-022-00254-w |
0.555 |
|
| 2021 |
Dabee S, Tanko RF, Brown BP, Bunjun R, Balle C, Feng C, Konstantinus IN, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Gill K, Baeten JM, Bekker LG, Passmore JS, ... Heffron R, et al. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis. Frontiers in Immunology. 12: 760504. PMID 34956191 DOI: 10.3389/fimmu.2021.760504 |
0.457 |
|
| 2021 |
Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM. Incidence of herpes simplex virus type 2 infection among African women using depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a nested randomized trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34910143 DOI: 10.1093/cid/ciab1027 |
0.446 |
|
| 2021 |
Rousseau E, Katz AWK, O'Rourke S, Bekker LG, Delany-Moretlwe S, Bukusi E, Travill D, Omollo V, Morton JF, O'Malley G, Haberer JE, Heffron R, Johnson R, Celum C, Baeten JM, et al. Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya. Plos One. 16: e0258542. PMID 34648589 DOI: 10.1371/journal.pone.0258542 |
0.528 |
|
| 2021 |
Deese J, Heffron R, Jaspan H, Masson L, Smit JA, Sibeko S. Recent Advances and New Challenges in Cisgender Women's Gynecologic and Obstetric Health in the Context of HIV. Clinical Obstetrics and Gynecology. 64: 475-490. PMID 34323229 DOI: 10.1097/GRF.0000000000000627 |
0.631 |
|
| 2021 |
Beesham I, Issema R, Palanee-Phillips T, Onono M, Evans S, Beksinska M, Ahmed K, Kasaro MP, Batting J, Deese J, Dlamini L, Yankurije B, Thomas KK, Heffron R. ART initiation among women newly diagnosed with HIV in a contraceptive trial in sub-Saharan Africa. Aids Care. 1-8. PMID 34180277 DOI: 10.1080/09540121.2021.1944601 |
0.651 |
|
| 2021 |
Ngure K, Trinidad SB, Beima-Sofie K, Kinuthia J, Matemo D, Kimemia G, Njoroge A, Achiro L, Pintye J, Mugo NR, Bukusi EA, Baeten JM, Heffron R, John-Stewart G, Kelley MC. Perceived Social Influences on Women's Decisions to use Medications not Studied in Pregnancy. A Qualitative Ethical Analysis of Preexposure Prophylaxis Implementation Research in Kenya. Journal of Empirical Research On Human Research Ethics : Jerhre. 16: 225-237. PMID 34133231 DOI: 10.1177/15562646211012296 |
0.521 |
|
| 2021 |
Donnell D, Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, et al. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study. The Lancet. Hiv. PMID 34126052 DOI: 10.1016/S2352-3018(21)00048-5 |
0.687 |
|
| 2021 |
Heffron R, Casmir E, Aswani L, Ngure K, Kwach B, Ogello V, Kiptinness C, Ambiyo F, Wairimu N, Ossome E, Machafu H, Zia Y, Thomas D, Scoville C, Barker T, et al. HIV risk and pre-exposure prophylaxis interest among women seeking post-abortion care in Kenya: a cross-sectional study. Journal of the International Aids Society. 24: e25703. PMID 33973355 DOI: 10.1002/jia2.25703 |
0.611 |
|
| 2021 |
Zia Y, Velloza J, Oluoch L, Momanyi R, Mbugua S, Njoroge J, Gakuo S, Mugo E, Thuo N, Kiptinness C, Njuguna N, Ngure K, R Mugo N, Heffron R. Use of fertility awareness methods as a component of safer conception for women in HIV-serodifferent relationships in Kenya. Reproductive Health. 18: 73. PMID 33794936 DOI: 10.1186/s12978-021-01128-5 |
0.662 |
|
| 2021 |
Nickolas TL, Barasch J, Mugwanya KK, Branch AD, Heffron R, Wanga V, Mugo NR, Ronald A, Celum C, Donnell D, Baeten JM, Wyatt CM. Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis. Aids (London, England). PMID 33710023 DOI: 10.1097/QAD.0000000000002865 |
0.486 |
|
| 2020 |
Noël-Romas L, Perner M, Molatlhegi R, Farr Zuend C, Mabhula A, Hoger S, Lamont A, Birse K, Berard A, McCorrister S, Westmacott G, Leslie A, Poliquin V, Heffron R, McKinnon LR, et al. Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition. Plos Pathogens. 16: e1009097. PMID 33362285 DOI: 10.1371/journal.ppat.1009097 |
0.577 |
|
| 2020 |
Bulterys MA, Sharma M, Mugwanya K, Stein G, Mujugira A, Nakyanzi A, Twohey-Jacobs L, Ware NC, Heffron R, Celum C. Correlates of HIV status non-disclosure by pregnant women living with HIV to their male partners in Uganda: a cross-sectional study. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33148995 DOI: 10.1097/QAI.0000000000002566 |
0.639 |
|
| 2020 |
Musinguzi N, Kidoguchi L, Mugo NR, Ngure K, Katabira E, Celum CL, Baeten JM, Heffron R, Haberer JE. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy. Bmc Public Health. 20: 1621. PMID 33115478 DOI: 10.1186/s12889-020-09712-3 |
0.741 |
|
| 2020 |
Muwonge TR, Nsubuga R, Brown C, Nakyanzi A, Bagaya M, Bambia F, Katabira E, Kyambadde P, Baeten JM, Heffron R, Celum C, Mujugira A, Haberer JE. Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda. Plos One. 15: e0241399. PMID 33112907 DOI: 10.1371/journal.pone.0241399 |
0.6 |
|
| 2020 |
Beesham I, Heffron R, Evans S, Baeten JM, Smit J, Beksinska M, Mansoor LE. Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial. Aids and Behavior. PMID 33106996 DOI: 10.1007/s10461-020-03072-0 |
0.688 |
|
| 2020 |
Ngure K, Velloza J, Patel RC, Mugo NR, Bukusi EA, Haberer JE, Odoyo J, Celum C, Baeten JM, Heffron R. Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships. International Journal of Std & Aids. 956462420951501. PMID 32998640 DOI: 10.1177/0956462420951501 |
0.645 |
|
| 2020 |
Pintye J, Davey DLJ, Wagner AD, John-Stewart G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Groves AK, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre JA, et al. Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework. The Lancet. Hiv. 7: e582-e592. PMID 32763221 DOI: 10.1016/S2352-3018(20)30102-8 |
0.748 |
|
| 2020 |
Peebles K, Palanee-Phillips T, Balkus JE, Beesham I, Makkan H, Deese J, Smit J, Heffron R, Morrison CS, Philip NM, Malahleha M, Kasaro M, Naidoo Y, Nielson T, Reddy K, et al. Age-specific risk scores do not improve HIV-1 prediction among women in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32701820 DOI: 10.1097/Qai.0000000000002436 |
0.609 |
|
| 2020 |
Stalter R, Mugwanya K, Thomas K, Donnell D, Mujugira A, Ngure K, Celum C, Kidoguchi L, Bukusi E, Baeten J, Heffron R. Sexual behaviors following PrEP discontinuation among HIV serodiscordant couples in Kenya and Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32658130 DOI: 10.1097/Qai.0000000000002434 |
0.745 |
|
| 2020 |
Onono M, Nanda K, Heller KB, Taylor D, Yacobson I, Heffron R, Kasaro MP, Louw CE, Nhlabasti Z, Palanee-Phillips T, Smit J, Wakhungu I, Gichangi PB, Mugo NR, Morrison C, et al. Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception. Contraception: X. 2: 100026. PMID 32577615 DOI: 10.1016/j.conx.2020.100026 |
0.405 |
|
| 2020 |
Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, et al. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial. Journal of the International Aids Society. 23: e25491. PMID 32396700 DOI: 10.1002/Jia2.25491 |
0.784 |
|
| 2020 |
Morrison CS, Hofmeyr GJ, Thomas KK, Rees H, Philip N, Palanee-Phillips T, Nanda K, Nair G, Onono M, Mastro TD, Lind M, Heffron R, Edward V, Deese J, Beksinska M, et al. Effects of depot medroxyprogesterone acetate, copper intrauterine devices, and levonorgestrel implants on early HIV disease progression. Aids Research and Human Retroviruses. PMID 32394723 DOI: 10.1089/Aid.2020.0015 |
0.685 |
|
| 2020 |
Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, Hosek S, Heffron R, Bekker LG, Mgodi N, Chirenje M, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. Journal of the International Aids Society. 23: e25463. PMID 32144874 DOI: 10.1002/Jia2.25463 |
0.518 |
|
| 2020 |
Velloza J, Njoroge J, Ngure K, Thuo N, Kiptinness C, Momanyi R, Ayub S, Gakuo S, Mugo N, Simoni J, Heffron R. Cognitive testing of the PHQ-9 for depression screening among pregnant and postpartum women in Kenya. Bmc Psychiatry. 20: 31. PMID 31996166 DOI: 10.1186/S12888-020-2435-6 |
0.392 |
|
| 2020 |
Velloza J, Heffron R, Amico KR, Rowhani-Rahbar A, Hughes JP, Li M, Dye BJ, Celum C, Bekker LG, Grant RM. The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT. Aids and Behavior. PMID 31955360 DOI: 10.1007/S10461-020-02783-8 |
0.4 |
|
| 2020 |
Wanga V, Baeten JM, Bukusi EA, Mugo NR, Asiimwe S, Ngure K, Mujugira A, Muwonge T, Odoyo JB, Haberer JE, Celum C, Heffron R. Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa. Aids and Behavior. PMID 31925607 DOI: 10.1007/S10461-019-02773-5 |
0.755 |
|
| 2020 |
Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre J, Moodley D, et al. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? Journal of the International Aids Society. 23: e25426. PMID 31912985 DOI: 10.1002/Jia2.25426 |
0.735 |
|
| 2019 |
Ortblad KF, Stalter RM, Bukusi EA, Ngure K, Mujugura A, Celum C, Baeten JM, Heffron R. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda. Aids and Behavior. PMID 31696370 DOI: 10.1007/S10461-019-02720-4 |
0.723 |
|
| 2019 |
Nickolas TL, Yin MT, Hong T, Mugwanya KK, Branch AD, Heffron R, Ramalho J, Nandakumar R, Dworakowski E, Wanga V, Mugo NR, Ronald A, Celum C, Donnell D, Baeten JM, et al. Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults. Open Forum Infectious Diseases. 6: ofz338. PMID 31660332 DOI: 10.1093/Ofid/Ofz338 |
0.667 |
|
| 2019 |
Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples. Journal of Acquired Immune Deficiency Syndromes (1999). 82: 265-274. PMID 31609925 DOI: 10.1097/Qai.0000000000002139 |
0.77 |
|
| 2019 |
Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS. Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204]. Contraception. 100: 88. PMID 31229224 DOI: 10.1016/J.Contraception.2019.05.014 |
0.649 |
|
| 2019 |
Kimemia G, Ngure K, Baeten JM, Celum C, Dew K, Njuguna N, Mugo N, Heffron R. Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya. Reproductive Health. 16: 85. PMID 31215447 DOI: 10.1186/S12978-019-0751-4 |
0.78 |
|
| 2019 |
Irungu EM, Sharma M, Maronga C, Mugo N, Ngure K, Celum C, Barnabas RV, Baeten J, Heffron R. The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya. Aids Research and Treatment. 2019: 4170615. PMID 31186955 DOI: 10.1155/2019/4170615 |
0.735 |
|
| 2019 |
Pyra M, Anderson P, Haberer JE, Heffron R, Celum C, Asiimwe S, Katabira E, Mugo NR, Bukusi EA, Baeten JM. Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women. Frontiers in Pharmacology. 10: 401. PMID 31057407 DOI: 10.3389/Fphar.2019.00401 |
0.611 |
|
| 2019 |
Velloza J, Ngure K, Kiptinness C, Quame-Amaglo J, Thuo N, Dew K, Kimani M, Gakuo S, Unger JA, Kolko B, Baeten JM, Celum C, Mugo N, Heffron R. A clinic-based tablet application to support safer conception among HIV serodiscordant couples in Kenya: feasibility and acceptability study. Mhealth. 5: 4. PMID 30976596 DOI: 10.21037/mhealth.2019.01.04 |
0.747 |
|
| 2019 |
Heffron R, Ngure K, Velloza J, Kiptinness C, Quame-Amalgo J, Oluch L, Thuo N, Njoroge J, Momanyi R, Gakuo S, Mbugua S, Morrison S, Haugen H, Chohan B, Celum C, et al. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness. Journal of the International Aids Society. 22: e25261. PMID 30957420 DOI: 10.1002/Jia2.25261 |
0.767 |
|
| 2018 |
Heffron R, Stalter R, Pyra M, Nanda K, Erikson DW, Hladik F, Blue SW, Davis NL, Mugo N, Kourtis AP, Lingappa JR, Baeten JM. HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study. Aids (London, England). PMID 30585845 DOI: 10.1097/Qad.0000000000002123 |
0.72 |
|
| 2018 |
Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women. Contraception. PMID 30576636 DOI: 10.1016/J.Contraception.2018.12.001 |
0.626 |
|
| 2018 |
Beima-Sofie KM, Trinidad SB, Ngure K, Heffron R, Baeten JM, John-Stewart GC, Kelley M. Lessons from PrEP: A Qualitative Study Investigating How Clinical and Policy Experts Weigh Ethics and Evidence When Evaluating Preventive Medications for Use in Pregnant and Breastfeeding Women. Aids and Behavior. PMID 30552519 DOI: 10.1007/S10461-018-2361-5 |
0.635 |
|
| 2018 |
Davies N, Heffron R. Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding. Sexual Health. 15: 501-512. PMID 30447703 DOI: 10.1071/Sh18067 |
0.574 |
|
| 2018 |
Muwonge TR, Ngure K, Katabira E, Mugo N, Kimemia G, Burns BFO, Musinguzi N, Bambia F, Baeten JM, Heffron R, Haberer JE. Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study. Aids and Behavior. PMID 30406335 DOI: 10.1007/S10461-018-2326-8 |
0.712 |
|
| 2018 |
Velloza J, Baeten JM, Haberer J, Ngure K, Irungu E, Mugo N, Celum C, Heffron R. The Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30063651 DOI: 10.1097/Qai.0000000000001821 |
0.523 |
|
| 2018 |
Pintye J, Beima-Sofie KM, Makabong'O PA, Njoroge A, Trinidad SB, Heffron RA, Baeten JM, Celum C, Matemo D, Kinuthia J, Kelley MC, John-Stewart GC. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Preexposure Prophylaxis During Pregnancy. Aids Patient Care and Stds. PMID 30036072 DOI: 10.1089/Apc.2018.0058 |
0.753 |
|
| 2018 |
Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM. Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. Aids and Behavior. PMID 30006791 DOI: 10.1007/S10461-018-2221-3 |
0.738 |
|
| 2018 |
Musinguzi N, Muwonge T, Ngure K, Katabira E, Mugo N, Burns BFO, Baeten JM, Heffron R, Haberer JE. Comparison of SMS self-reported adherence with other adherence measures in a demonstration project of HIV pre-exposure prophylaxis in Kenya and Uganda. Aids (London, England). PMID 30005025 DOI: 10.1097/Qad.0000000000001955 |
0.594 |
|
| 2018 |
Heffron R, Mugo N, Hong T, Celum C, Marzinke MA, Ngure K, Asiimwe S, Katabira E, Bukusi EA, Odoyo J, Tindimwebwa E, Bulya N, Baeten JM. Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention. Aids (London, England). 32: 1707-1713. PMID 30001244 DOI: 10.1097/Qad.0000000000001867 |
0.738 |
|
| 2018 |
Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM, et al. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral pre-exposure prophylaxis. Aids (London, England). PMID 29894385 DOI: 10.1097/Qad.0000000000001922 |
0.733 |
|
| 2018 |
Ware NC, Pisarski EE, Nakku-Joloba E, Wyatt MA, Muwonge TR, Turyameeba B, Asiimwe SB, Heffron RA, Baeten JM, Celum CL, Katabira ET. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda. Journal of the International Aids Society. 21: e25113. PMID 29851436 DOI: 10.1002/Jia2.25113 |
0.651 |
|
| 2018 |
Heffron R, Mugo N, Hong T, Celum C, Marzinke MA, Ngure K, Asiimwe S, Katabira E, Bukusi E, Odoyo J, Tindimwebwa E, Bulya N, Baeten JM. Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention. Aids (London, England). PMID 29762175 DOI: 10.1097/QAD.0000000000001867 |
0.695 |
|
| 2018 |
Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, Ngure K, Kiarie J, Mugo N, Heffron R. Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners. The Journal of Infectious Diseases. PMID 29514254 DOI: 10.1093/Infdis/Jiy113 |
0.793 |
|
| 2018 |
Hancuch K, Baeten J, Ngure K, Celum C, Mugo N, Tindimwebwa E, Heffron R. Safer conception among HIV-1 serodiscordant couples in East Africa: understanding knowledge, attitudes, and experiences. Aids Care. 1-9. PMID 29455572 DOI: 10.1080/09540121.2018.1437251 |
0.766 |
|
| 2018 |
Pyra M, Lingappa JR, Heffron R, Erikson DW, Blue SW, Patel RC, Nanda K, Rees H, Mugo NR, Davis NL, Kourtis AP, Baeten JM. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women. Contraception. PMID 29408422 DOI: 10.1016/J.Contraception.2018.01.011 |
0.687 |
|
| 2018 |
Blue SW, Winchell AJ, Kaucher AV, Lieberman RA, Gilles CT, Pyra MN, Heffron R, Hou X, Coombs RW, Nanda K, Davis NL, Kourtis AP, Herbeck JT, Baeten JM, Lingappa JR, et al. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS. Contraception. PMID 29407362 DOI: 10.1016/J.Contraception.2018.01.015 |
0.402 |
|
| 2017 |
Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, Kidoguchi L, Donnell D, Mugo NR, Bukusi EA, Katabira E, Asiimwe S, Morton J, Morrison S, Haugen H, et al. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Research. 1: 3. PMID 29355231 DOI: 10.12688/gatesopenres.12752.1 |
0.758 |
|
| 2017 |
Ngure K, Trinidad SB, Beima-Sofie K, Baeten JM, Mugo NR, Bukusi EA, Heffron R, John-Stewart G, Kelley MC. The role of male partners in women's participation in research during pregnancy: a case study from the partners demonstration project. Reproductive Health. 14: 160. PMID 29297375 DOI: 10.1186/S12978-017-0424-0 |
0.604 |
|
| 2017 |
Mugwanya KK, Baeten JM, Wyatt C, Mugo NR, Celum CL, Ronald A, Kiarie J, Katabira E, Heffron R. Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29135656 DOI: 10.1097/Qai.0000000000001575 |
0.648 |
|
| 2017 |
Cabral A, Baeten J, Ngure K, Velloza J, Odoyo J, Haberer J, Celum C, Muwonge T, Asiimwe S, Heffron R. Intimate partner violence and self-reported pre-exposure prophylaxis (PrEP) interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29076883 DOI: 10.1097/Qai.0000000000001574 |
0.772 |
|
| 2017 |
Thomson KA, Dhanireddy S, Andrasik M, Hancuch K, Legg L, Keane-Candib J, Heffron R. Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. Aids Care. 1-9. PMID 29067843 DOI: 10.1080/09540121.2017.1390541 |
0.717 |
|
| 2017 |
Pintye J, Baeten JM, Celum C, Mugo N, Ngure K, Were E, Bukusi E, John-Stewart G, Heffron RA. Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study. The Journal of Infectious Diseases. PMID 29040666 DOI: 10.1093/Infdis/Jix542 |
0.614 |
|
| 2017 |
Pyra M, Haberer JE, Heffron R, Kidoguchi L, Brown ER, Bukusi EA, Asiimwe S, Celum C, Katabira E, Mugo NR, Baeten JM. PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29016523 DOI: 10.1097/Qai.0000000000001561 |
0.764 |
|
| 2017 |
Haberer JE, Ngure K, Muwonge T, Mugo N, Katabira E, Heffron R, Musinguzi N, Bangsberg DR, Celum C, Baeten JM. Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28961676 DOI: 10.1097/Qai.0000000000001548 |
0.744 |
|
| 2017 |
Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odoyo J, Tindimwebwa E, Bulya N, Katabira E, Heffron R. High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy. Aids Research and Human Retroviruses. PMID 28899162 DOI: 10.1089/AID.2017.0020 |
0.661 |
|
| 2017 |
Heffron R, Thomson K, Celum C, Haberer J, Ngure K, Mugo N, Bukusi E, Katabira E, Odoyo J, Bulya N, Asiimwe S, Tindimwebwa E, Baeten JM. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples. Aids and Behavior. PMID 28894986 DOI: 10.1007/S10461-017-1902-7 |
0.791 |
|
| 2017 |
Velloza J, Heffron R. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women. Current Hiv/Aids Reports. PMID 28812207 DOI: 10.1007/S11904-017-0362-Z |
0.643 |
|
| 2017 |
Pintye J, Beima-Sofie KM, Kimemia G, Ngure K, Trinidad SB, Heffron R, Baeten J, Odoyo J, Mugo N, Bukusi EA, Kelley MC, John-Stewart GC. "I did not want to give birth to a child who has HIV": Experiences using PrEP during pregnancy among HIV-uninfected Kenyan women in HIV-serodiscordant couples. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28777265 DOI: 10.1097/Qai.0000000000001516 |
0.754 |
|
| 2017 |
Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. Journal of the International Aids Society. 20: 1-9. PMID 28741331 DOI: 10.7448/Ias.20.1.21842 |
0.753 |
|
| 2017 |
Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, Bukusi E, Donnell D, Lingappa J, Kiarie J, Fiedler T, Munch M, Fredricks DN, Baeten JM. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. The Lancet. Hiv. PMID 28732773 DOI: 10.1016/S2352-3018(17)30110-8 |
0.705 |
|
| 2017 |
Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda. Aids and Behavior. PMID 28634661 DOI: 10.1007/S10461-017-1829-Z |
0.614 |
|
| 2017 |
Matthews LT, Beyeza-Kashesya J, Cooke I, Davies N, Heffron R, Kaida A, Kinuthia J, Mmeje O, Semprini AE, Weber S. Consensus statement: Supporting Safer Conception and Pregnancy For Men And Women Living with and Affected by HIV. Aids and Behavior. PMID 28501964 DOI: 10.1007/S10461-017-1777-7 |
0.641 |
|
| 2017 |
Patel RC, Baeten JM, Heffron R, Hong T, Davis NL, Nanda K, Coombs RW, Lingappa JR, Bukusi EA, Hurst S, Thomas KK, Kourtis AP, Mugo N. Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data. Journal of Acquired Immune Deficiency Syndromes (1999). 75: 91-96. PMID 28399558 DOI: 10.1097/QAI.0000000000001339 |
0.707 |
|
| 2017 |
Ngure K, Heffron R, Mugo N, Thomson KA, Irungu E, Njuguna N, Mwaniki L, Celum C, Baeten JM. Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya. Journal of the International Aids Society. 20: 1-8. PMID 28362073 DOI: 10.7448/Ias.20.1.21234 |
0.763 |
|
| 2017 |
Ngure K, Kimemia G, Dew K, Njuguna N, Mugo N, Celum C, Baeten JM, Heffron R. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples. Journal of the International Aids Society. 20: 52-58. PMID 28361508 DOI: 10.7448/Ias.20.2.21309 |
0.776 |
|
| 2017 |
Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R, et al. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 74: S15-S22. PMID 27930607 DOI: 10.1097/Qai.0000000000001210 |
0.775 |
|
| 2017 |
Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R, et al. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 74: S15-S22. PMID 27923009 DOI: 10.1097/QAI.0000000000001210 |
0.747 |
|
| 2017 |
Pyra M, Lingappa J, Erikson D, Blue S, Heffron R, Mugo N, Nanda K, Davis N, Kourtis A, Baeten J. Validity of self-reported hormonal contraceptive use among women with and at risk for HIV American Journal of Obstetrics and Gynecology. 217: 737. DOI: 10.1016/J.Ajog.2017.08.030 |
0.684 |
|
| 2016 |
Smith JA, Heffron R, Butler AR, Celum C, Baeten JM, Hallett TB. Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk? Contraception. PMID 28038949 DOI: 10.1016/J.Contraception.2016.12.003 |
0.689 |
|
| 2016 |
Pintye J, Drake AL, Kinuthia J, Unger JA, Matemo D, Heffron R, Barnabas R, Kohler P, McClelland RS, John-Stewart G. A risk assessment tool for identifying pregnant and postpartum women who may benefit from pre-exposure prophylaxis (PrEP). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28034882 DOI: 10.1093/Cid/Ciw850 |
0.54 |
|
| 2016 |
Kourtis AP, Wiener J, King CC, Heffron R, Mugo NR, Nanda K, Pyra M, Donnell D, Celum C, Lingappa JR, Baeten JM. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-infected African women. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27787340 DOI: 10.1097/Qai.0000000000001199 |
0.649 |
|
| 2016 |
Irungu EM, Heffron R, Mugo N, Ngure K, Katabira E, Bulya N, Bukusi E, Odoyo J, Asiimwe S, Tindimwebwa E, Celum C, Baeten JM. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention. Bmc Infectious Diseases. 16: 571. PMID 27751179 DOI: 10.1186/S12879-016-1899-Y |
0.776 |
|
| 2016 |
Heffron R, Parikh UM, Penrose KJ, Mugo N, Donnell D, Celum C, Mellors JW, Baeten JM. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception. Aids and Behavior. PMID 27699594 DOI: 10.1007/S10461-016-1563-Y |
0.69 |
|
| 2016 |
Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Hendrix C, Marzinke MA, et al. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. Plos Medicine. 13: e1002099. PMID 27552090 DOI: 10.1371/Journal.Pmed.1002099 |
0.766 |
|
| 2016 |
Carroll JJ, Heffron R, Mugo N, Ngure K, Ndase P, Asiimwe S, Celum C, Baeten JM. Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis. Sexually Transmitted Diseases. 43: 471-475. PMID 27419812 DOI: 10.1097/Olq.0000000000000472 |
0.699 |
|
| 2016 |
Ngure K, Vusha S, Mugo N, Emmanuel-Fabula M, Ngutu M, Celum C, Baeten JM, Heffron R. "I never thought that it would happen … " Experiences of HIV seroconverters among HIV-discordant partnerships in a prospective HIV prevention study in Kenya. Aids Care. 1-4. PMID 27264119 DOI: 10.1080/09540121.2016.1191610 |
0.778 |
|
| 2016 |
Njuguna N, Ngure K, Mugo N, Sambu C, Sianyo C, Gakuo S, Irungu E, Baeten J, Heffron R. The Effect of Human Immunodeficiency Virus Prevention and Reproductive Health Text Messages on Human Immunodeficiency Virus Testing Among Young Women in Rural Kenya: A Pilot Study. Sexually Transmitted Diseases. 43: 353-359. PMID 27200519 DOI: 10.1097/Olq.0000000000000450 |
0.708 |
|
| 2016 |
Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, Baeten JM. Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy. The Journal of Infectious Diseases. PMID 27053765 DOI: 10.1093/Infdis/Jiw131 |
0.725 |
|
| 2016 |
Heffron R, Pintye J, Matthews LT, Weber S, Mugo N. PrEP as Peri-conception HIV Prevention for Women and Men. Current Hiv/Aids Reports. PMID 26993627 DOI: 10.1007/S11904-016-0312-1 |
0.74 |
|
| 2016 |
Ngure K, Heffron R, Curran K, Vusha S, Ngutu M, Mugo N, Celum C, Baeten JM. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation. Aids Patient Care and Stds. 30: 78-83. PMID 26836236 DOI: 10.1089/Apc.2015.0259 |
0.783 |
|
| 2016 |
Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya. Aids Care. 1-7. PMID 26754017 DOI: 10.1080/09540121.2015.1131972 |
0.852 |
|
| 2016 |
Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 1-7. DOI: 10.1080/09540121.2015.1131972 |
0.708 |
|
| 2015 |
Heffron R, Cohen CR, Ngure K, Bukusi E, Were E, Kiarie J, Mugo N, Celum C, Baeten JM. A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy. Plos One. 10: e0145515. PMID 26720412 DOI: 10.1371/Journal.Pone.0145515 |
0.761 |
|
| 2015 |
Heffron R, Davies N, Cooke I, Kaida A, Mergler R, van der Poel S, Cohen CR, Mmeje O. A discussion of key values to inform the design and delivery of services for HIV-affected women and couples attempting pregnancy in resource-constrained settings. Journal of the International Aids Society. 18: 20272. PMID 26643454 DOI: 10.7448/Ias.18.6.20272 |
0.7 |
|
| 2015 |
Pyra M, Heffron R, Mugo NR, Nanda K, Thomas KK, Celum C, Kourtis AP, Were E, Rees H, Bukusi E, Baeten JM. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. Aids (London, England). 29: 2353-9. PMID 26544706 DOI: 10.1097/Qad.0000000000000827 |
0.663 |
|
| 2015 |
Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women. Current Opinion in Hiv and Aids. PMID 26417954 DOI: 10.1097/Coh.0000000000000207 |
0.743 |
|
| 2015 |
Pintye J, Ngure K, Curran K, Vusha S, Mugo N, Celum C, Baeten JM, Heffron R. Fertility Decision-Making Among Kenyan HIV-Serodiscordant Couples Who Recently Conceived: Implications for Safer Conception Planning. Aids Patient Care and Stds. 29: 510-6. PMID 26301703 DOI: 10.1089/Apc.2015.0063 |
0.853 |
|
| 2015 |
Ying R, Sharma M, Heffron R, Celum CL, Baeten JM, Katabira E, Bulya N, Barnabas RV. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda. Journal of the International Aids Society. 18: 20013. PMID 26198348 DOI: 10.7448/Ias.18.4.20013 |
0.761 |
|
| 2015 |
Baeten JM, Heffron R. Contraception and sexually transmitted infections: risks and benefits, hypotheses and evidence. The Lancet. Global Health. 3: e430-1. PMID 26094163 DOI: 10.1016/S2214-109X(15)00085-6 |
0.6 |
|
| 2015 |
Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. Plos Medicine. 12: e1001778. PMID 25612136 DOI: 10.1371/Journal.Pmed.1001778 |
0.799 |
|
| 2015 |
Ying R, Sharma M, Heffron R, Celum CL, Baeten JM, Katabira E, Bulya N, Barnabas RV. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda Journal of the International Aids Society. 18. DOI: 10.7448/IAS.18.4.20013 |
0.438 |
|
| 2014 |
Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. Aids (London, England). 28: 2771-6. PMID 25493602 DOI: 10.1097/Qad.0000000000000493 |
0.778 |
|
| 2014 |
Pintye J, Baeten JM, Manhart LE, Celum C, Ronald A, Mugo N, Mujugira A, Cohen C, Were E, Bukusi E, Kiarie J, Heffron R. Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples. The Lancet. Global Health. 2: e664-71. PMID 25442691 DOI: 10.1016/S2214-109X(14)70315-8 |
0.664 |
|
| 2014 |
Were EO, Heffron R, Mugo NR, Celum C, Mujugira A, Bukusi EA, Baeten JM. Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men. Aids (London, England). 28: 1977-82. PMID 25259704 DOI: 10.1097/Qad.0000000000000313 |
0.748 |
|
| 2014 |
Matthews LT, Heffron R, Mugo NR, Cohen CR, Hendrix CW, Celum C, Bangsberg DR, Baeten JM. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 91-7. PMID 25118795 DOI: 10.1097/Qai.0000000000000246 |
0.746 |
|
| 2014 |
Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial. Jama. 312: 362-71. PMID 25038355 DOI: 10.1001/Jama.2014.8735 |
0.692 |
|
| 2014 |
Roberts ST, Heffron R, Ngure K, Celum C, Kurth A, Curran K, Mugo N, Baeten JM. Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples. Aids and Behavior. 18: 1701-11. PMID 24871870 DOI: 10.1007/S10461-014-0804-1 |
0.847 |
|
| 2014 |
Murnane PM, Heffron R, Ronald A, Bukusi EA, Donnell D, Mugo NR, Were E, Mujugira A, Kiarie J, Celum C, Baeten JM. Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception. Aids (London, England). 28: 1825-30. PMID 24785951 DOI: 10.1097/Qad.0000000000000290 |
0.796 |
|
| 2014 |
Ngure K, Baeten JM, Mugo N, Curran K, Vusha S, Heffron R, Celum C, Shell-Duncan B. My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya. Aids Care. 26: 1283-7. PMID 24779445 DOI: 10.1080/09540121.2014.911808 |
0.859 |
|
| 2014 |
Baeten JM, Heffron R. Pre-exposure prophylaxis to intensify the fight against HIV. The Lancet. Infectious Diseases. 14: 443-5. PMID 24613083 DOI: 10.1016/S1473-3099(14)70070-2 |
0.74 |
|
| 2014 |
Heffron R, Donnell D, Kiarie J, Rees H, Ngure K, Mugo N, Were E, Celum C, Baeten JM. A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 231-6. PMID 24442226 DOI: 10.1097/Qai.0000000000000013 |
0.722 |
|
| 2014 |
Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, Celum C, Baeten JM. 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy. Aids (London, England). 28: 227-33. PMID 24413310 DOI: 10.1097/Qad.0000000000000025 |
0.85 |
|
| 2013 |
Polis CB, Westreich D, Balkus JE, Heffron R. Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. Aids (London, England). 27: S35-43. PMID 24088682 DOI: 10.1097/Qad.0000000000000036 |
0.631 |
|
| 2013 |
Curran K, Mugo NR, Kurth A, Ngure K, Heffron R, Donnell D, Celum C, Baeten JM. Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women. Aids and Behavior. 17: 2977-85. PMID 23695519 DOI: 10.1007/S10461-013-0510-4 |
0.786 |
|
| 2013 |
Mujugira A, Heffron R, Celum C, Mugo N, Nakku-Joloba E, Baeten JM. Fertility intentions and interest in early antiretroviral therapy among East African HIV-1-infected individuals in serodiscordant partnerships. Journal of Acquired Immune Deficiency Syndromes (1999). 63: e33-5. PMID 23574927 DOI: 10.1097/Qai.0B013E318288Bb32 |
0.789 |
|
| 2013 |
Heffron R, Mugo N, Ngure K, Celum C, Donnell D, Were E, Rees H, Kiarie J, Baeten JM. Hormonal contraceptive use and risk of HIV-1 disease progression. Aids (London, England). 27: 261-7. PMID 23079806 DOI: 10.1097/Qad.0B013E32835Ad473 |
0.756 |
|
| 2013 |
Heffron RA, Donnell D, Mugo N, Celum C, Rees H, Ngure K, Were E, Kiarie J, Baeten JM. P3.200 Effect of Pregnancy on HIV-1 Disease Progression Among Antiretroviral-Naive HIV-1 Infected Women Sexually Transmitted Infections. 89: A210.3-A211. DOI: 10.1136/Sextrans-2013-051184.0657 |
0.61 |
|
| 2012 |
Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K, Baeten JM. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 116-9. PMID 22595872 DOI: 10.1097/Qai.0B013E31825Da73F |
0.873 |
|
| 2012 |
Ngure K, Heffron R, Mugo NR, Celum C, Cohen CR, Odoyo J, Rees H, Kiarie JN, Were E, Baeten JM. Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships. Aids (London, England). 26: 513-8. PMID 22156966 DOI: 10.1097/Qad.0B013E32834F981C |
0.746 |
|
| 2012 |
Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. The Lancet. Infectious Diseases. 12: 19-26. PMID 21975269 DOI: 10.1016/S1473-3099(11)70247-X |
0.8 |
|
| 2012 |
Ngure K, Ng’ang’a Z, Kimani V, Khamadi S, Onchiri F, Irungu E, Heffron R, Were E, Mugo N. Correlates of contraceptive use among HIVdiscordant couples in Kenya African Population Studies. 26. DOI: 10.11564/26-1-221 |
0.724 |
|
| 2012 |
Heffron R, Rees H, Mugo N, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission - Authors' reply The Lancet Infectious Diseases. 12: 510-511. DOI: 10.1016/S1473-3099(12)70153-6 |
0.737 |
|
| 2012 |
Ngure K, Ng’ang’a Z, Kimani V, Khamadi S, Onchiri F, Irungu E, Heffron R, Were E, Mugo N. Correlates of contraceptive use among HIV discordant couples in Kenya Etude De La Population Africaine. 26: 87-95. |
0.676 |
|
| 2011 |
Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin Í, Delany S, Garnett GP, Gray G, Johnson L, McIntyre J, Rees H, Celum C. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. Plos Medicine. 8: e1001123. PMID 22110407 DOI: 10.1371/Journal.Pmed.1001123 |
0.748 |
|
| 2011 |
Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, Celum C, Kiarie JN, Cohen CR, Kayintekore K, Baeten JM. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. Aids (London, England). 25: 1887-95. PMID 21785321 DOI: 10.1097/Qad.0B013E32834A9338 |
0.798 |
|
| 2011 |
Heffron R, Chao A, Mwinga A, Sinyangwe S, Sinyama A, Ginwalla R, Shields JM, Kafwembe E, Kaetano L, Mulenga C, Kasongo W, Mukonka V, Bulterys M. High prevalent and incident HIV-1 and herpes simplex virus 2 infection among male migrant and non-migrant sugar farm workers in Zambia. Sexually Transmitted Infections. 87: 283-8. PMID 21459898 DOI: 10.1136/sti.2010.045617 |
0.564 |
|
| 2011 |
Mujugira A, Morrow RA, Celum C, Lingappa J, Delany-Moretlwe S, Fife KH, Heffron R, De Bruyn G, Homawoo B, Karita E, Mugo N, Vwalika B, Baeten JM. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sexually Transmitted Infections. 87: 238-41. PMID 21307152 DOI: 10.1136/Sti.2010.047415 |
0.63 |
|
| 2011 |
Ngure K, Baeten J, Lingappa J, Heffron R, Musingila P, Irungu E, Mwaniki P, Mwaniki L, Wamae R, Mburu S, Mugo N. P1-S6.02 Contraceptive discontinuation by rural Kenyan women in HIV discordant partnerships after exiting an HIV prevention trial Sexually Transmitted Infections. 87: A196-A196. DOI: 10.1136/Sextrans-2011-050108.226 |
0.753 |
|
| 2010 |
Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J, Baeten JM. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sexually Transmitted Diseases. 37: 621-8. PMID 20601930 DOI: 10.1097/Olq.0B013E3181E1A162 |
0.776 |
|
| 2009 |
Ngure K, Heffron R, Mugo N, Irungu E, Celum C, Baeten JM. Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. Aids (London, England). 23: S89-95. PMID 20081393 DOI: 10.1097/01.Aids.0000363781.50580.03 |
0.762 |
|
| Show low-probability matches. |